TNF and stroke disorder: HSCT has been used in patients with a severe phenotype (10, 17–19) that did not respond to medical treatments such as tumor necrosis factor (TNF) inhibitors, which represent the best option in controlling fever episodes and vasculopathy and in preventing stroke (1, 20, 21).